Contract 47QFWA20C0012
Abss Solutions Inc · General Services Administration · September 8, 2020
Abss Solutions Inc was awarded a federal contract by General Services Administration (Federal Acquisition Service) on September 8, 2020 for $115.75 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Lackland Afb, TX. It was awarded under an 8(a) sole-source set-aside. The contract has been modified 96 times since the base award It uses time-and-materials contract pricing. The most recent modification was on July 3, 2025.
Contract details
- PIID
- 47QFWA20C0012
- Award type
- Definitive Contract
- Pricing
- Time And Materials
- Set-aside
- 8a Competed
- Competition
- Full And Open Competition After Exclusion Of Sources
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Basic Research
- Place of performance
- Lackland Afb, TX
- First action
- September 8, 2020
- Latest action
- July 3, 2025
Description
OPTION YEAR 4 CEILING/FUNDING REALIGNMENT AND INCREMENTAL FUNDS FOR THE 59TH MEDICAL WING SCIENCE TECHNOLOGY START.
Modification timeline
-
July 3, 2025Mod P00096$18.0K
-
May 13, 2025Mod P00095OPTION YEAR 2 AND YEAR 3 CEILING REALIGNMENT AND OPTION YEAR 4 INCREMENTAL FUNDS FOR THE 59TH MEDICAL WING SCIENCE TECHNOLOGY START.$443.7K
-
April 2, 2025Mod P00094MIGRATED ID07200010 59MDW SCIENCE TECHNOLOGY START$-668.4K
-
January 23, 2025Mod P00093MIGRATED ID07200010 59MDW SCIENCE TECHNOLOGY START$486.2K
-
September 25, 2024Mod P00092MIGRATED ID07200010 59MDW SCIENCE TECHNOLOGY START$552.7K
-
September 23, 2024Mod P00091MIGRATED ID07200010 59MDW SCIENCE TECHNOLOGY START$5.96M
-
August 26, 2024Mod P00090MIGRATED ID07200010 59MDW SCIENCE TECHNOLOGY START$-2.18M
-
July 18, 2024Mod P00089MIGRATED ID07200010 59MDW SCIENCE TECHNOLOGY START$292.1K
-
July 2, 2024Mod P00088MIGRATED ID07200010 59MDW SCIENCE TECHNOLOGY START$-992.4K
-
May 9, 2024Mod P00087MIGRATED ID07200010 59MDW SCIENCE TECHNOLOGY START$639.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Icon Government And Public Health Solutions, Inc. | General Services Administration | March 23, 2026 | $0 |
| Global Science & Technology, Llc | General Services Administration | March 4, 2026 | $0 |
| Capital I Llc | General Services Administration | January 23, 2026 | $0 |
| The Mcconnell Group, Inc. | General Services Administration | December 29, 2025 | $0 |
| Texas A&M Agrilife Research | General Services Administration | December 18, 2025 | $0 |
| Goldbelt Frontier, Llc | General Services Administration | December 1, 2025 | $0 |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | The Boeing Company | 1 | $4.44B |
| 2 | Advanced Technology International | 9 | $3.35B |
| 3 | Amgen USA Inc | 2 | $774.69M |
| 4 | Siga Technologies, Inc. | 1 | $624.44M |
| 5 | Icon Government And Public Health Solutions, Inc. | 16 | $404.80M |
| 6 | Technical Resources International, Inc. | 19 | $395.29M |
| 7 | Allucent Government Services (Us) Llc | 9 | $384.26M |
| 8 | Mapp Biopharmaceutical, Inc. | 7 | $354.24M |
| 9 | Ppd Development Lp | 18 | $331.02M |
| 10 | Albert B. Sabin Vaccine Institute, Inc. (The) | 2 | $305.87M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 47QFWA20C0012?
Contract 47QFWA20C0012 is a federal contract awarded to Abss Solutions Inc by General Services Administration on September 8, 2020 for $115.75 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 96 times since the base award.
Who won contract 47QFWA20C0012?
Abss Solutions Inc won contract 47QFWA20C0012 from General Services Administration.
How much is contract 47QFWA20C0012 worth?
Contract 47QFWA20C0012 has obligated $115.75 million to date, with a total potential value of $126.10 million if all options are exercised.